| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $31.6M | $38.6M | $11.6M |
| YoY Revenue Growth % | -18.2% | +233.3% | — |
| Gross Profit | $2.3M | $20.7M | — |
| Gross Margin % | 7.2% | 53.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.0M | $403.0K | -$9.2M |
| Operating Margin % | -47.4% | 1.0% | -79.0% |
| Net Income (GAAP) | -$6.8M | $7.1M | -$3.8M |
| EBITDA (Normalized) | -$14.4M | $1.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.3M | -$18.9M | -$665.0K |
| Capital Expenditures (CapEx) | $674.0K | $1.4M | — |
| Free Cash Flow (FCF) | -$14.0M | -$20.3M | -$665.0K |
| FCF Margin % | -44.2% | -52.7% | -5.7% |
| Return on Invested Capital (ROIC %) | -11.0% | 0.3% | — |
| Cash & Short-Term Equivalents | $31.7M | $44.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $139.6M | $138.8M | — |